Thiant et al. findings suggest that early monitoring of IL-7/IL-15 kinetics could guide clinical interventions, with IL-15 pathway inhibition representing a potential therapeutic strategy for acute GVHD prevention [31]. Here, IL7 is linked to graft versus host disease.